Lifestyle change and high-density lipoprotein change: The US Department of Veterans Affairs normative aging study

Clinical Cardiology

Volumn 35, Issue 7, 2012, Pages 437-442

  Rahilly Tierney, Catherine ^a,b,c,d   Vokonas, Pantel ^a,c,e   Gaziano, J Michael ^a,b,c,d   Spiro III, Avron ^a,e,f  

^a HealthCare System   (United States)

^b Divisions of Aging   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRINKING BEHAVIOR; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; SMOKING; SMOKING CESSATION;

EID: 84863461852     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21978     Document Type: Article

References (20)

1. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977; 62: 707-714. (Pubitemid 8110784)
2. Castelli WP, Garrison RJ, Wilson PWF, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986; 256: 2835-2838. (Pubitemid 17178361)
3. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989; 79: 8-15. (Pubitemid 19043669)
4. Stampfer MJ, Sacks FM, Salvini S, et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991; 325: 373-381.
5. Miller NE, Thelle DS, Forde OH, et al. The Tromsø heart-study: High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977; 1: 965-968.
6. Perova NV, Organov RG, Williams DH, et al. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable disease in samples of US and Russian men. Ann Epidemiol. 1995; 3: 179-185.
7. Stensvold I, Urdal P, Thurmer H, et al. High-density lipoprotein cholesterol and coronary, cardiovascular, and all cause mortality among middle-aged Norwegian men and women. Eur Heart J. 1992; 13: 1155-1163.
8. Enger SC, Hjermann I, Foss OP, et al. High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery. 1979; 5: 170-181. (Pubitemid 9135915)
9. Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986; 8: 1245-1255. (Pubitemid 17208898)
10. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med. 1987; 317: 1237-1245. (Pubitemid 17147964)
11. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999; 341: 410-418. (Pubitemid 29362514)
12. Rahilly-Tierney C, Bowman TS, Djousse L, et al. Change in high-density lipoprotein cholesterol and coronary heart disease in apparently healthy male physicians. Am J Cardiol. 2008; 102: 1663-1667.
13. Singh IM, Shishehbor MH, Ansell BJ., High-density lipoprotein as a therapeutic target. JAMA. 2007; 298: 786-798.
14. Leon AS, Gaskill SE, Rice T, et al. Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Int J Sports Med. 2002; 23: 1-9. (Pubitemid 34033015)
15. Asztalos B, Lefevre M, Wong L, et al. Differential response to low-fat diet between low and normal HDL-C cholesterol subjects. J Lipid Res. 2000; 41: 321-328. (Pubitemid 30183614)
16. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993; 329: 1829-1834. (Pubitemid 23360481)
17. Ellison RC, Zhang Y, Qureshi MM, et al. Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2004; 147: 529-535. (Pubitemid 38880878)
18. Weisskopf MG, Jain N, Nie H, et al. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation. 2009; 120: 1056-1064.
19. Criqui MH., Triglycerides and coronary heart disease revisited (again). Ann Intern Med. 2007; 147: 425-427. (Pubitemid 351664544)
20. American Heart Association Web site. NHLBI decision to stop AIM-HIGH trial. http://newsroom.heart.org/pr/aha/1350.aspx. Accessed June 8, 2011.